Zheng Quan Zhi Xing·2025-08-22 16:24Group 1 - The report is a tracking report by Western Securities Co., Ltd. regarding Hunan Jiutian Pharmaceutical Co., Ltd. for the first half of 2025 [1] - The report includes an overview of the sponsor's work, detailing the review of company information disclosure documents and compliance with regulations [1][2] - The company has not failed to review information disclosure documents, with zero instances of non-compliance noted [1] Group 2 - The company has established a complete set of regulations, including measures to prevent related party transactions and manage raised funds [1] - The company effectively executes relevant regulations, as confirmed by the sponsor [1] - The report indicates that the company attended one shareholder meeting and has conducted two checks on the special fund account for raised funds [1] Group 3 - The report states that there are no significant issues requiring attention from the sponsor [1][2] - The company has not failed to fulfill any commitments, and there are no unresolved issues reported [2]